ReviewMolecular psychiatry2026
Changes in peripheral immune cell phenotypes and their roles in autism: insights from clinical and animal model studies.
Review in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mesenchymal stem/stromal cell-based therapies for autism spectrum disorder: emerging evidence and clinical prospects.Journal of translational medicine · 2026Review
- Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Autism Spectrum Disorder (ASD), a group of highly heterogeneous and multifactorial neurodevelopmental disorders, is characterized by core clinical manifestations, including social deficits and repetitive stereotyped behaviors. Although its etiology involves both genetic and environmental factors, the exact pathogenesis remains elusive. Recent biological studies have untangled a pathological framework related to the "immune-neurodevelopmental axis", which has emerged as a potential paradigm for deciphering the complex mechanisms underlying ASD. In this framework, adaptive and innate immunity dysfunctions are thought to potentially contribute to disease progression. This review integrates evidence from clinical cohort studies and animal models to elucidate the functional phenotypic alterations of the three major peripheral immune cell subsets in ASD. Furthermore, it explores the multidimensional cascade of pathogenic mechanisms in which peripheral lymphocyte phenotypes may be involved, thereby providing collective evidence to support the future development of immune-modulatory therapeutic strategies for ASD.
Indexed as
Identifiers
41258377What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.